IRISH JOURNAL OF MEDICAL SCIENCE爱尔兰医学科学杂志
IRISH JOURNAL OF MEDICAL SCIENCE(英文缩写 IRISH J MED SCI),ISSN 0021-1265,eISSN 1863-4362,中文译名:爱尔兰医学科学杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-11-01 至 2026-10-31，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 2.089 | Q3 |
| 2022 | 2.100 | Q3 |
| 2023 | 1.700 | Q2 |
| 2024 | 1.600 | Q2 |
| 2025 | 2.000 | Q2 |
IRISH JOURNAL OF MEDICAL SCIENCE 最新收录文献
-
1. Microneedling with topical platelet-rich plasma versus triamcinolone acetonide for the treatment of alopecia areata in children: a comparative study.
1. 微针联合局部富血小板血浆与曲安奈德治疗儿童斑秃的比较研究PMID:日期:2026-10-02Alopecia areata (AA) is a common autoimmune, non-scarring hair loss disorder that presents without visible inflammation, and can substantially affect children and their families. To compare the efficacy and tolerability of microneedling-assisted topical platelet-rich plasma (PRP) versus microneedling-assisted topical triamcinolone acetonide in children with localized alopecia areata. This prospective comparative study included 30 children with localized AA. Participants were allocated into two equal groups using an alternate allocation method. Group I (n = 15) received microneedling with topical PRP, whereas Group II (n = 15) received microneedling with topical triamcinolone acetonide. Baseline index patch size (p = 0.841) and SALT (Severity of Alopecia Tool) scores (p = 0.08) did not differ significantly between groups. At week 12, Group II had a significantly lower mean SALT score than Group I (1.73 vs. 3.10; p = 0.042) and a greater mean percentage improvement in SALT score (66.4% vs. 18.5%; p < 0.001). Within-group analysis showed significant improvement in both groups (both p < 0.001). Patient satisfaction was significantly higher in Group II (Mann-Whitney U = 39.0, p = 0.002). Both treatments were well tolerated, with no major adverse events. Microneedling-assisted topical triamcinolone acetonide produced greater short-term improvement in SALT scores and patient satisfaction than PRP in children with localized AA. These findings support it as an effective and well-tolerated therapeutic option; however, larger randomized controlled studies with longer follow-up are needed to confirm comparative efficacy and long-term outcomes.
-
2. The effect of beta-blockers in heart failure with preserved ejection fraction and atrial fibrillation: systematic review and meta-analysis.
2. β受体阻滞剂在射血分数保留型心力衰竭合并心房颤动中的疗效：系统评价与荟萃分析PMID:日期:2026-10-02Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) frequently coexist and together confer a substantially elevated risk of adverse cardiovascular outcomes. Despite the widespread clinical use of beta-blockers for rate control in this population, their prognostic impact remains unresolved, with existing evidence derived predominantly from observational cohorts subject to confounding by indication. To evaluate the association of beta-blocker therapy with all-cause mortality, cardiovascular mortality, heart failure hospitalization, and composite outcomes in patients with coexisting HFpEF and AF through a systematic review and meta-analysis. Online databases (MEDLINE and Scopus) were searched from inception through March 2026 for studies reporting on the effects of beta-blockers in patients with HFpEF and AF. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using the DerSimonian and Laird random-effects model. Heterogeneity was quantified using the I statistic. Leave-one-out sensitivity analyses and pre-specified subgroup analyses by study design and follow-up duration were performed. Nine studies were included (n = 31,888; beta-blocker group n = 24,683; control n = 7,205). Beta-blocker therapy was associated with a statistically significant reduction in all-cause mortality (HR: 0.88; 95% CI: 0.83-0.93; P < 0.0001; I = 44.9%) and cardiovascular mortality (HR: 0.91; 95% CI: 0.84-0.99; P = 0.023; I = 0%). No statistically significant differences were observed for heart failure hospitalization (HR: 0.88; 95% CI: 0.70-1.10; P = 0.264; I = 62.5%) or the composite outcome (HR: 0.89; 95% CI: 0.77-1.02; P = 0.084; I = 70.7%). In leave-one-out analyses, exclusion of Yang 2020 yielded statistically significant reductions in both all-cause mortality and heart failure hospitalization with elimination or reduction of heterogeneity. In patients with HFpEF and concomitant AF, beta-blocker therapy is associated with significant reductions in all-cause and cardiovascular mortality. No significant benefit was observed for heart failure hospitalization or composite outcomes in primary analyses, though sensitivity analyses were supportive. These findings, derived from observational data, support a permissive clinical approach to beta-blocker use in this population, particularly for rate control in those with elevated heart rates. Adequately powered randomized controlled trials specifically targeting HFpEF with AF are urgently needed to establish causal efficacy.
-
3. Comparison of the effect of connective tissue massage and foam roller in fibromyalgia patients.
PMID:日期:2026-10-02The purpose of this study was to compare the effects of foam roller (FR) and connective tissue massage (CTM) in pain, function, sleep quality, and quality of life in patients with Fibromyalgia Syndrome (FMS). Forty female participants with FMS were randomly assigned to CTM group or Foam Roller (FR) group. Both interventions were applied twice in a week for 6 weeks. The Michigan Body Map (MBM), Visual Analog Scale (VAS), Health Assessment Questionnaire (HAQ), Pittsburgh Sleep Quality Index (PSQI), and Fibromyalgia Impact Questionnaire (FIQ) were used to evaluate pain localization, pain, quality of life, sleep quality and function, respectively. All measurements demonstrated significant post-treatment improvements in both groups (p < 0.001). Comparisons between groups showed that CTM led to more improvements in pain localization (p < 0.001) and function (p = 0.033). Between-group comparisons revealed that the CTM group achieved greater improvements in functional status (p < 0.001), fibromyalgia impact (p = 0.005), and pain localization (p < 0.001) compared with the FR group. This study was concluded the improvement of all assesments both in CTM and FR groups. In addition, CTM demonstrated greater advantages in terms of functional independence and pain management, indicating that it might be a better treatment choice for fibromyalgia symptoms.
-
4. Atopic dermatitis management: integrating disease mechanisms with precision medicine and nanotechnology-based targeted therapies.
PMID:日期:2026-09-29Atopic Dermatitis is a chronic, multi-factorial skin inflammation disorder characterized by immune dysregulation, skin barrier dysfunction, microbial imbalance and environmental triggers. Despite advances in conventional and biological therapies, challenges persist in early diagnosis, disease classification, treatment personalization and long-term management. Emerging technologies integrating precision medicine and nanotechnology offer promising solutions to address these limitations. This review aims to highlight the integration of precision medicine and advanced nanocarrier systems into the prediction, diagnosis and targeted treatment of atopic dermatitis. This review identifies key gaps in clinical, translational and personalized dermatological research. The review gives deep insights into current evidence on clinical practices and multi-omics approaches for AD phenotyping, biomarker discovery, disease severity assessment, and prediction of advanced therapeutic approaches. The integration of multi-omics data approaches and translational research methods significantly enhance the classification of disease severity, and provides wonders in discovery of potential biomarkers for measuring response and suggesting treatment. Integrating these multidisciplinary approaches has the potential to optimize patient stratification, improve treatment outcomes, and advance sustainable dermatological care.
-
5. Should we use the SARC-F score in sarcopenia screening in kidney transplant patients?
5. 我们是否应在肾移植患者的肌少症筛查中使用SARC-F评分？PMID:日期:2026-09-26The risk of sarcopenia is increased in kidney transplant (KT) patients. The SARC-F score is a reliable tool used for sarcopenia screening; however, it has not been tested in KT patients. The aim of our study is to assess the prevalence of sarcopenia in KT recipients and to investigate the relationship between the SARC-F score and sarcopenia parameters. The study included 150 KT patients. Body muscle mass was measured using the Tanita DC 360 ST device. Before these measurements, patients were scored using the five-question SARC-F assessment, and their scores were recorded. 28 patients were diagnosed with sarcopenia, yielding a sarcopenia prevalence of 18.7%. The mean age of the patients was 42.1 ± 13.5 years. Correlation analysis of SARC-F scoring results revealed a negative correlation between SARC-F and total muscle mass, muscle percentage, skeletal muscle mass, skeletal muscle index, grip strength, and walking speed parameters, as expected. Analysis of SARC-F scores showed that only 12 of the 150 patients had a SARC-F score greater than 4. Patients with a SARC-F score ≥ 4 had lower muscle percentage, total muscle mass, skeletal muscle mass, handgrip strength, and walking speed than those with a score < 4. However, only one of these patients met the criteria for sarcopenia. The findings of this study indicate that the SARC-F score is associated with muscle mass and strength parameters in KT patients and may be used as a screening tool. However, it is not sufficient as a standalone diagnostic tool for sarcopenia.
-
6. Hands on or held back? Procedural experience during a neonatal rotation in Ireland.
6. 亲自动手还是退居一旁？爱尔兰新生儿轮转期间的操作经验PMID:日期:2026-09-26Neonatology is a core component of paediatric training in Ireland and Europe. However, the procedural experience of Senior House Officers (SHOs) during neonatal rotations in Ireland has not previously been formally reported. Concerns have been raised regarding the impact of the European Working Time Directive (EWTD) on postgraduate medical training. At the Coombe Hospital, implementation of an EWTD-compliant rota reduced SHO on-call duties from 16 to 12 hours. This study aimed to describe the procedural experience of a Senior House Officer during a six-month neonatal rotation under a 12-hour EWTD-compliant rota. We retrospectively audited the clinical logbook of an SHO during a six month rotation (July-December 2024) at the Coombe Hospital, a Level III perinatal centre in Dublin. The SHO attended 120 deliveries; 91% were term births and the remainder preterm, including four extremely preterm infants, with the earliest gestation attended being 22+5 weeks. The SHO participated in 12 neonatal resuscitations, acted as first responder on seven, and independently delivered intermittent positive pressure ventilation on four occasions. They completed 218 routine neonatal discharge examinations, identifying significant findings. Procedural exposure comprised six intravenous cannulations, 40 phlebotomies and one assisted umbilical line insertion. No opportunities arose for lumbar puncture, central line insertion or endotracheal intubation. Although exposure to deliveries, neonatal resuscitation and newborn examinations was adequate, hands-on procedural experience was limited. As this rotation is often the only neonatal exposure before progressing to registrar level, reduced shift length may adversely affect training and the acquisition of core competencies.
-
7. Correction to: Why and how the long case became the OSLER-the sum of the parts.
PMID:日期:2026-09-25该文献暂无摘要。
-
9. Teach-back versus video-assisted instruction for improving nursing students' knowledge, self-efficacy and skills in safe medical device use.
PMID:日期:2026-09-24Nursing students' proficiency in medical device use is critical for patient safety. However, this training is often unstructured in nursing curricula, necessitating evidence-based practice. To compare the effects of teach-back and video-assisted instruction on nursing students' knowledge, self-efficacy, and skills in safe medical device use. A randomized controlled trial with a repeated-measures design was conducted among 91 final-year nursing students (teach-back = 31, video = 30, control = 30). Training focused on bedside monitors, infusion pumps, and suction devices. Knowledge, self-efficacy, and skills were assessed. The findings indicated that the teach-back and video-assisted teaching groups had significantly higher average scores in knowledge, self-efficacy, and skills than the control group (p < 0.001). Although no statistically significant difference was found between the teach-back and video-assisted teaching groups regarding knowledge and skills scores (p > 0.05), the self-efficacy scores were significantly higher in the teach-back group (p < 0.05). Both teach-back and video-assisted instruction significantly improved nursing students' knowledge, self-efficacy, and psychomotor skills in safe medical device use compared to the control group. While both methods were equally effective in knowledge and skill acquisition, teach-back demonstrated a superior effect in enhancing self-efficacy. Given their complementary strengths, future educational strategies could explore integrating video-assisted instruction with teach-back to optimize both skill competency and self-efficacy. NCT05354687.
-
10. The relationship between maternal c-type natriuretic peptide levels and fetal growth restriction.
PMID:日期:2026-09-24To investigate maternal serum C-type natriuretic peptide (CNP) levels in pregnancies with different fetal growth patterns and to evaluate the ability of CNP to discriminate pathological fetal growth restriction (FGR) from non-pathological fetal smallness. This prospective study included 180 singleton pregnancies classified as appropriate-for-gestational-age, constitutionally small with normal Doppler, or pathological FGR with abnormal Doppler. Maternal serum) levels were measured, and appropriate statistical methods were applied to evaluate their ability to distinguish pathological FGR from non-pathological smallness. Maternal age, gravidity, and parity were similar across groups (p > 0.05), while BMI differed significantly (p < 0.001). Gestational age at delivery and birth weight decreased progressively from Group 1 to Group 3 (p < 0.001). Maternal serum CNP levels varied significantly (p < 0.001), being highest in pathological FGR. Post-hoc analysis confirmed higher CNP in Group 3 versus Groups 1 and 2 (p < 0.001), with a smaller difference between Groups 1 and 2 (p = 0.039). CNP correlated negatively with gestational age (r = - 0.277) and birth weight (r = - 0.466) (p < 0.001). ROC analysis showed excellent accuracy for detecting pathological FGR (AUC = 0.908, 95% CI: 0.857-0.959), with a cutoff of 644.3 pg/mL yielding 95% sensitivity and 80.8% specificity. Maternal serum CNP levels are significantly elevated in pregnancies with pathological fetal growth restriction but not in constitutionally small fetuses. This suggests that CNP reflects placental insufficiency rather than normal smallness and may serve as a useful biomarker to differentiate pathological from non-pathological fetal growth.